ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction

OBJECTIVES: Anoctamin 1 (ANO1) has been found to be overexpressed in esophageal squamous cell carcinoma (ESCC) in our previous study. Herein we showed the clinical relevance of ANO1 alterations with ESCC and esophageal precancerous lesion progression. RESULTS: ANO1 was detected in 38.1% (109/286) an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Shang, Li, Hao, Jia-Jie, Zhao, Xue-Ke, He, Jian-Zhong, Shi, Zhi-Zhou, Liu, Hui-Juan, Wu, Li-Fei, Jiang, Yan-Yi, Shi, Feng, Yang, Hai, Zhang, Yu, Liu, Yi-Zhen, Zhang, Tong-Tong, Xu, Xin, Cai, Yan, Jia, Xue-Mei, Li, Min, Zhan, Qi-Min, Li, En-Min, Wang, Li-Dong, Wei, Wen-Qiang, Wang, Ming-Rong
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029708/
https://ncbi.nlm.nih.gov/pubmed/27016410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8223
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares